tert-Butyl 3-((2-(5-cyanopyrazin-2-ylamino)-5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate → 5-(5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)-4-(piperidin-3-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile
Reaction equation
[C:1]([C:3]1[N:4]=[CH:5][C:6]([NH:9][C:10]2[CH:15]=[C:14]([NH:16][CH2:17][CH:18]3[CH2:23][CH2:22][CH2:21][N:20](C(OC(C)(C)C)=O)[CH2:19]3)[C:13]([N:31]3[CH:35]=[CH:34][C:33]([CH2:36][N:37]4[CH2:42][CH2:41][O:40][CH2:39][CH2:38]4)=[CH:32]3)=[CH:12][N:11]=2)=[N:7][CH:8]=1)#[N:2]>CO>[O:40]1[CH2:41][CH2:42][N:37]([CH2:36][C:33]2[CH:34]=[CH:35][N:31]([C:13]3[C:14]([NH:16][CH2:17][CH:18]4[CH2:23][CH2:22][CH2:21][NH:20][CH2:19]4)=[CH:15][C:10]([NH:9][C:6]4[N:7]=[CH:8][C:3]([C:1]#[N:2])=[N:4][CH:5]=4)=[N:11][CH:12]=3)[CH:32]=2)[CH2:38][CH2:39]1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
Crude tert-butyl 3-((2-(5-cyanopyrazin-2-ylamino)-5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate (90 mg) was dissolved in methanol (1 mL) and absorbed onto a TsOH solid phase extraction cartridge and allowed to stand for 2 h. The cartridge was eluted with 7M ammonia in methanol. The basic fractions were evaporated to dryness. The crude product was purified by HPLC to give 5-(5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)-4-(piperidin-3-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile (4.93 mg, 7% over 3 steps).
Workup
- customabsorbed onto a TsOH solid phase extraction cartridge
- washThe cartridge was eluted with 7M ammonia in methanol
- customThe basic fractions were evaporated to dryness
- customThe crude product was purified by HPLC
Sources & evidence
- ORD record
- ord-aed0ead6bb2e45a8bd80801902528de9
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08367658B2
Reaction notes
Loading…